» Articles » PMID: 39077184

Mechanism of Hypercholesterolemia-Induced Atherosclerosis

Overview
Date 2024 Jul 30
PMID 39077184
Authors
Affiliations
Soon will be listed here.
Abstract

Hypercholesterolemia is involved in the development of atherosclerosis and is a risk factor for coronary artery disease, stroke, and peripheral vascular disease. This paper deals with the mechanism of development of hypercholesterolemic atherosclerosis. Hypercholesterolemia increases the formation of numerous atherogenic biomolecules including reactive oxygen species (ROS), proinflammatory cytokines [interleukin (IL)-1, IL-2, IL-6, IL-8, tumor necrosis factor-alpha (TNF- )], expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), granulocyte macrophage-colony stimulating factor (GM-CSF) and numerous growth factors [insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-1 (PDGF-1) and transforming growth factor-beta (TGF- )]. ROS mildly oxidizes low-density lipoprotein-cholesterol (LDL-C) to form minimally modified LDL (MM-LDL) which is further oxidized to form oxidized LDL (OX-LDL). Hypercholesterolemia also activates nuclear factor-kappa-B (NF- B). The above atherogenic biomolecules are involved in the development of atherosclerosis which has been described in detail. Hypercholesterolemia also assists in the development of atherosclerosis through AGE (advanced glycation end-products)-RAGE (receptor for AGE) axis and C-reactive protein (CRP). Hypercholesterolemia is associated with increases in AGE, oxidative stress [AGE/sRAGE (soluble receptor for AGE)] and C-reactive protein, and decreases in the sRAGE, which are known to be implicated in the development of atherosclerosis. In conclusion, hypercholesterolemia induces atherosclerosis through increases in atherogenic biomolecules, AGE-RAGE axis and CRP.

Citing Articles

Acute Toxicity and Antihyperlipidemic Effects of Syringaldehyde with Downregulation of SREBP-2 Gene Expression in Rats.

Imtiaz M, Shah N, Ikram M, Uddin Z, Qurat-Ul-Ain , Alamri A ACS Omega. 2025; 10(8):8619-8629.

PMID: 40060812 PMC: 11886728. DOI: 10.1021/acsomega.4c11184.


The protective effect and experimental research progress of pleotropic statins in intervertebral disc degeneration.

Zhang X, Li S, Liu X, Ma Z, Zhang Q, Zhang Y J Orthop Surg Res. 2025; 20(1):122.

PMID: 39891158 PMC: 11783947. DOI: 10.1186/s13018-025-05487-8.


Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD.

Rac M, Rac M, Krzystolik A, Safranow K, Chlubek D, Dziedziejko V Biomolecules. 2025; 15(1).

PMID: 39858417 PMC: 11763096. DOI: 10.3390/biom15010022.


Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment.

Prasad K Int J Angiol. 2024; 33(4):262-270.

PMID: 39502352 PMC: 11534477. DOI: 10.1055/s-0044-1788280.


Role of C-Reactive Protein, An Inflammatory Biomarker in The Development of Atherosclerosis and Its Treatment.

Prasad K Int J Angiol. 2024; 33(4):271-281.

PMID: 39502349 PMC: 11534478. DOI: 10.1055/s-0044-1788296.


References
1.
Ruzicka T, Printz M . Arachidonic acid metabolism in skin: a review. Rev Physiol Biochem Pharmacol. 1984; 100:121-60. DOI: 10.1007/3540133275_3. View

2.
Stuart M, Gerrard J, White J . Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N Engl J Med. 1980; 302(1):6-10. DOI: 10.1056/NEJM198001033020102. View

3.
Araujo F, Barbosa D, Hsin C, Maranhao R, Abdalla D . Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis. 1995; 117(1):61-71. DOI: 10.1016/0021-9150(94)05558-z. View

4.
Prasad K, Mishra M . AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease. Int J Angiol. 2018; 27(1):1-12. PMC: 5825221. DOI: 10.1055/s-0037-1613678. View

5.
Lee P, Prasad K . Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits. J Cardiovasc Pharmacol Ther. 2003; 8(3):227-35. DOI: 10.1177/107424840300800308. View